Cold Genesys Raises $10 Million from Ally Bridge and WI Harper

Cold Genesys, a Los Angeles-area onco-immunotherapy pharma, raised $10 million in a Series B funding led by two China-affiliated investors, Ally Bridge Group and WI Harper. One year ago, Cold Genesys raised $13.8 million in a Series A round from Ally Bridge. Cold Genesys will use the capital for a pivotal trial of CG0070, which is designed to replicate in tumors and create an immune response against cancer cells. More details.... Share this with colleagues: // //